Green light for study on stem cell therapy for newborns with brain damage

Researchers from UMC Utrecht have received the green light for a new study on stem cell therapy for newborns with brain damage. Thanks to a total grant of 5 million euros from Zorginstituut Nederland, ZonMw, the Brain Foundation Netherlands (Hersenstichting), and the Vrienden UMC Utrecht & Wilhelmina Children’s Hospital, the effectiveness of this promising therapy can now be tested. The study, called iSTOP-CP, is also supported by Maastricht UMC+, with whom UMC Utrecht has a long-standing collaboration on this research.